Institution
University of Aberdeen
Education•Aberdeen, United Kingdom•
About: University of Aberdeen is a education organization based out in Aberdeen, United Kingdom. It is known for research contribution in the topics: Population & Health care. The organization has 21174 authors who have published 49962 publications receiving 2105479 citations. The organization is also known as: Aberdeen University.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A review of the use of stable isotopes for hydrograph separation with particular reference to studies completed since the last comprehensive review in 1994 can be found in this paper, where the authors examine the role of soil water as a contributor to channel stormflow and the issues raised by differences in the soil water and groundwater signatures at watershed scale.
478 citations
••
TL;DR: This large, multi-ethnic genome-wide association study identifies 97 loci significantly associated with atrial fibrillation that are enriched for genes involved in cardiac development, electrophysiology, structure and contractile function.
Abstract: Atrial fibrillation (AF) affects more than 33 million individuals worldwide1 and has a complex heritability2. We conducted the largest meta-analysis of genome-wide association studies (GWAS) for AF to date, consisting of more than half a million individuals, including 65,446 with AF. In total, we identified 97 loci significantly associated with AF, including 67 that were novel in a combined-ancestry analysis, and 3 that were novel in a European-specific analysis. We sought to identify AF-associated genes at the GWAS loci by performing RNA-sequencing and expression quantitative trait locus analyses in 101 left atrial samples, the most relevant tissue for AF. We also performed transcriptome-wide analyses that identified 57 AF-associated genes, 42 of which overlap with GWAS loci. The identified loci implicate genes enriched within cardiac developmental, electrophysiological, contractile and structural pathways. These results extend our understanding of the biological pathways underlying AF and may facilitate the development of therapeutics for AF.
477 citations
••
TL;DR: An equation for the flux of electrolyte through a water-swollen cation-exchange resin membrane separating two solutions of the same electrolyte at different concentrations is derived on the basis of several assumptions regarding the physical nature of a swollen resinous exchanger.
Abstract: An equation for the flux of electrolyte through a water-swollen cation-exchange resin membrane separating two solutions of the same electrolyte at different concentrations is derived on the basis of several assumptions regarding the physical nature of a swollen resinous exchanger. The complete flux equation contains three terms, one determined by the concentration difference across the membrane, another determined by the variation of the activity coefficient of the electrolyte with concentration in the membrane and a third concerned with the rate of osmotic or hydrostatic flow through the membrane. If ions in the resin are transported entirely in an internal aqueous phase, the mobilities required for the flux equation can be related to mobilities in aqueous solution and to the volume fraction of resin in the swollen membrane. The treatment is readily extended to anion exchangers.
476 citations
••
TL;DR: This paper compares and contrast the objectives of principal component analysis and exploratory factor analysis, and suggests that in some cases it may be useful to rotate certain principal components if and when that is appropriate.
Abstract: In this paper we compare and contrast the objectives of principal component analysis and exploratory factor analysis. This is done through consideration of nine examples. Basic theory is presented in appendices. As well as covering the standard material, we also describe a number of recent developments. As an alternative to factor analysis, it is pointed out that in some cases it may be useful to rotate certain principal components if and when that is appropriate.
475 citations
••
Aneurin Bevan University Health Board1, Cardiff University2, King's College London3, University of Salford4, University of Manchester5, University of Glasgow6, North Bristol NHS Trust7, University of Modena and Reggio Emilia8, Aberdeen Royal Infirmary9, Woodend Hospital10, Alexandra Hospital11, University of Aberdeen12
TL;DR: The prevalence of frailty in patients with COVID-19 who were admitted to hospital is established and its association with mortality and duration of hospital stay is investigated and disease outcomes were better predicted by frailty than either age or comorbidity.
Abstract: Background
The COVID-19 pandemic has placed unprecedented strain on health-care systems. Frailty is being used in clinical decision making for patients with COVID-19, yet the prevalence and effect of frailty in people with COVID-19 is not known. In the COVID-19 in Older PEople (COPE) study we aimed to establish the prevalence of frailty in patients with COVID-19 who were admitted to hospital and investigate its association with mortality and duration of hospital stay.
Methods
This was an observational cohort study conducted at ten hospitals in the UK and one in Italy. All adults (≥18 years) admitted to participating hospitals with COVID-19 were included. Patients with incomplete hospital records were excluded. The study analysed routinely generated hospital data for patients with COVID-19. Frailty was assessed by specialist COVID-19 teams using the clinical frailty scale (CFS) and patients were grouped according to their score (1–2=fit; 3–4=vulnerable, but not frail; 5–6=initial signs of frailty but with some degree of independence; and 7–9=severe or very severe frailty). The primary outcome was in-hospital mortality (time from hospital admission to mortality and day-7 mortality).
Findings
Between Feb 27, and April 28, 2020, we enrolled 1564 patients with COVID-19. The median age was 74 years (IQR 61–83); 903 (57·7%) were men and 661 (42·3%) were women; 425 (27·2%) had died at data cutoff (April 28, 2020). 772 (49·4%) were classed as frail (CFS 5–8) and 27 (1·7%) were classed as terminally ill (CFS 9). Compared with CFS 1–2, the adjusted hazard ratios for time from hospital admission to death were 1·55 (95% CI 1·00–2·41) for CFS 3–4, 1·83 (1·15–2·91) for CFS 5–6, and 2·39 (1·50–3·81) for CFS 7–9, and adjusted odds ratios for day-7 mortality were 1·22 (95% CI 0·63–2·38) for CFS 3–4, 1·62 (0·81–3·26) for CFS 5–6, and 3·12 (1·56–6·24) for CFS 7–9.
Interpretation
In a large population of patients admitted to hospital with COVID-19, disease outcomes were better predicted by frailty than either age or comorbidity. Our results support the use of CFS to inform decision making about medical care in adult patients admitted to hospital with COVID-19.
475 citations
Authors
Showing all 21424 results
Name | H-index | Papers | Citations |
---|---|---|---|
Paul M. Thompson | 183 | 2271 | 146736 |
Feng Zhang | 172 | 1278 | 181865 |
Ian J. Deary | 166 | 1795 | 114161 |
Peter A. R. Ade | 162 | 1387 | 138051 |
David W. Johnson | 160 | 2714 | 140778 |
Pete Smith | 156 | 2464 | 138819 |
Naveed Sattar | 155 | 1326 | 116368 |
John R. Hodges | 149 | 812 | 82709 |
Ruth J. F. Loos | 142 | 647 | 92485 |
Alan J. Silman | 141 | 708 | 92864 |
Michael J. Keating | 140 | 1169 | 76353 |
David Price | 138 | 1687 | 93535 |
John D. Scott | 135 | 625 | 83878 |
Aarno Palotie | 129 | 711 | 89975 |
Rajat Gupta | 126 | 1240 | 72881 |